SK bioscience Co. (302440.KS) reported a first quarter net loss attributable to shareholders of parent company of 33.3 billion korean won compared to a loss of 7.5 billion won, last year. Operating loss widened to 44.5 billion won compared to a loss of 15.1 billion won.
First quarter sales were 168.6 billion Korean won compared to 154.6 billion won, prior year, up 9.1%.
Shares of SK bioscience are trading at 44,100 won, up 1.85%.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.